Creative Biolabs Flexes Its Drug Discovery Muscle at the 21st BioPharma Drug Discovery Nexus Conference

Creative Biolabs is gearing up to take center stage at the 21st BioPharma Drug Discovery Nexus Conference this October.
New York, USA - October 14, 2024 - With booth #12, Creative Biolabs will be spotlighting solutions in drug development, designed to transform the way global scientists approach disease modeling and pharmacological research.

Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg

"In today's drug discovery landscape, in vitro and in vivo models are critical tools for testing potential therapies. While cell cultures and tissues have long been the workhorses of high-throughput screening, the shift toward using living animal models has opened a new frontier in understanding drug efficacy and safety." A scientist at Creative Biolabs says.

Creative Biolabs is right at the forefront of the disease model revolution, leveraging its expertise in animal models for drug discovery and delivering comprehensive solutions for pharmacology and pharmacodynamics (PK/PD) studies, antibacterial, and antifungal drug development [https://www.creative-biolabs.com/drug-discovery/therapeutics/antifungal-drug-discovery.htm]. These capabilities allow researchers to rapidly assess the efficacy and safety of new compounds in realistic, physiologically relevant environments.

Pharmacology and Pharmacodynamics Studies: Precision Meets Efficacy

At the conference, Creative Biolabs will highlight its extensive portfolio for pharmacology and pharmacodynamics (PK/PD) studies [https://www.creative-biolabs.com/drug-discovery/therapeutics/pk-pd-modeling.htm], which are essential for understanding how a drug behaves within the body-how it is absorbed, distributed, metabolized, and excreted, alongside its biological effects. The company's expertise in PK/PD modeling helps pharmaceutical developers predict optimal dosing, minimize side effects, and improve the overall therapeutic index of drugs, which ultimately speeds up the time it takes to bring a new therapy from the lab to the clinic.

Animal Models: A Key to Unlocking Therapeutic Success

Recent developments in in vivo screening techniques have revolutionized animal model applications in drug discovery, as published in Nature in August 2024. Creative Biolabs' comprehensive animal models for drug discovery [https://www.creative-biolabs.com/drug-discovery/therapeutics/animal-models.htm] provide researchers with customizable options tailored to specific diseases and therapeutic targets. Whether focused on oncology, immunotherapy, or infectious diseases, their high-quality models are designed to give researchers a leg up in understanding drug efficacy and safety in living systems.

* Xenograft Models

* Syngeneic Tumor Models for Antibody Screening

* Humanized Mouse Models

* Neurological Disease Models

Antibacterial Drug Discovery [https://www.creative-biolabs.com/drug-discovery/therapeutics/antibacterial-drug-discovery.htm]: Fighting the Good Fight

The rise of antibacterial and antifungal drug discovery has also become a hot topic, especially with the global health community emphasizing the need to combat antimicrobial resistance. Creative Biolabs is answering the call with its innovative antibacterial and antifungal drug discovery services, with a focus on developing novel compounds that can tackle resistant strains of bacteria and fungi. Attendees at the conference will have a chance to explore the platforms aimed at uncovering new therapeutics with diverse mechanisms of action, including inhibitors against cell wall biosynthesis, protein biosynthesis, membrane function, nucleic acid synthesis, and metabolic pathways.

With a range of services tailored for everything from early-stage drug screening to advanced pharmacodynamics, Creative Biolabs is inviting researchers, pharmaceutical companies, and industry professionals to drop by booth #12 to discuss how their solutions drive impactful results.

"Whether you're interested in groundbreaking PK/PD modeling, animal models, or antimicrobial drug development, this is an excellent opportunity to explore how we can accelerate your research and expedite the journey of your next breakthrough to the market." The scientist says.

For those unable to attend in person, Creative Biolabs encourages remote collaboration and engagement, ensuring that no one misses out on the exciting developments being showcased.

Web: https://www.creative-biolabs.com/drug-discovery/therapeutics

About

In an industry that's constantly evolving, Creative Biolabs is not just keeping pace-they're setting the standard. Stay tuned as they continue to power the next generation of therapies and push the boundaries of what's possible in drug discovery. Their team will also be participating in industry exhibitions throughout the rest of the year, including the Annual World ADC San Diego and Antibody Engineering & Therapeutics in December.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=creative-biolabs-flexes-its-drug-discovery-muscle-at-the-21st-biopharma-drug-discovery-nexus-conference]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/drug-discovery/therapeutics



This release was published on openPR.